Related Experiment Videos
[Coagulation factor XII deficiency, a contribution to thrombophilia]
Summary
Hereditary Hageman factor deficiency is rare and usually found incidentally. While patients do not experience bleeding, they are at risk for blood clots, necessitating thrombosis prevention.
Area of Science:
- Hematology
- Coagulation disorders
- Factor XII deficiency
Context:
- Hereditary deficiency of Hageman's factor (Factor XII) is an uncommon inherited bleeding disorder.
- Patients are typically asymptomatic and diagnosed incidentally through laboratory testing.
Purpose:
- To describe the clinical presentation and management of hereditary Hageman factor deficiency.
- To highlight the risk of thromboembolic events in affected individuals.
Summary:
- Hereditary Hageman's factor deficiency is a rare condition.
- The primary laboratory finding is a significantly prolonged partial thromboplastin time (PTT).
- Patients do not exhibit a hemorrhagic diathesis but have an increased risk of thrombosis.
Impact:
- Early diagnosis and recognition of thrombotic risk are crucial.
- Prophylactic anticoagulant therapy should be considered in diagnosed patients to prevent thromboembolic complications.